Silvana Cortés-Lagunes

Silvana Cortés-Lagunes

Auto-generated profile, based on publicly available information

Silvana Cortés-Lagunes

Instituto de Ciencias Aplicadas y Tecnología, Universidad Nacional Autónoma de México, Circuito Exterior S/N, Ciudad Universitaria, 04510 Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2023 in Separation and Purification Technology
Verified
Journal Article
Closed access
JDJuan C. Durán-Álvarez
Juan C. Durán-Álvarez
SCSilvana Cortés-Lagunes
Silvana Cortés-Lagunes
OMOlfa Mahjoub
Olfa Mahjoub
JLJOSE AMAURI SERRANO LAZARO
JOSE AMAURI SERRANO LAZARO
AGAndrea Garduño-Jiménez
Andrea Garduño-Jiménez
RZRodolfo Zanella
Rodolfo Zanella

4 August 2025 in Materials Chemistry and Physics
Verified
Journal Article
Open access
GBGuadalupe Vargas Bustamante
Guadalupe Vargas Bustamante
EBE. Benítez-Flores
E. Benítez-Flores
JDJuan C. Durán-Álvarez
Juan C. Durán-Álvarez
SCSilvana Cortés-Lagunes
Silvana Cortés-Lagunes
EAE.P. Arévalo-López
E.P. Arévalo-López
MRM. Romero
M. Romero

5 April 2024 in Microchemical Journal
Verified
Journal Article
Closed access
RCRuth Silvana Cortés-Lagunes
Ruth Silvana Cortés-Lagunes
AGAndrea-Lorena Garduño-Jiménez
Andrea-Lorena Garduño-Jiménez
ARAlonso Romero-Solano
Alonso Romero-Solano
Rodolfo ZanellaRodolfo Zanella
Rodolfo Zanella
BPBlanca Prado
Blanca Prado
Juan Carlos Durán-ÁlvarezJuan Carlos Durán-Álvarez
Juan Carlos Durán-Álvarez

2 March 2026 in Environmental Science: Processes & Impacts
Verified
Journal Article
Open access
PDF file
RCR. Silvana Cortés-Lagunes
R. Silvana Cortés-Lagunes
AGAndrea-Lorena Garduño-Jiménez
Andrea-Lorena Garduño-Jiménez
WBWenshi Bao
Wenshi Bao
Juan Carlos Durán-ÁlvarezJuan Carlos Durán-Álvarez
Juan Carlos Durán-Álvarez
FEFelicity C. T. Elder
Felicity C. T. Elder
LCLaura J. Carter
Laura J. Carter
Antibiotics are prevalent environmental pollutants with documented plant uptake and effects. Germination and seedling emergence are critical stages of plant development, making toxicity tests valuable for assessing the terrestrial risk. This study aims to address the need to understand species and antibiotic-dependent effects of 10 antibiotics across 23 plant species, including non-cultivated and geographically diverse species, through a Tier I phytotoxicity screening in which all antibiotics were tested at a single nominal concentration of 1 mg L−1, an upper-bound environmentally relevant scenario. Results revealed that antibiotic toxicity is highly species and antibiotic-dependent, highlighting the need to evaluate effects on under-studied species. Some global trends were observed; fluoroquinolones (ciprofloxacin, enrofloxacin, ofloxacin) stimulated germination and root growth in legumes and grasses, while black knapweed (Centaurea nigra) consistently exhibits germination reductions (30–53%) and root growth inhibition under all antibiotic exposures. Florfenicol exposure decreased root length and biomass in Chinese cabbage (Brassica rapa subs. Pekinensis) by nearly 100%, contrasting with stimulation observed in rice (Oryza sativa). The importance of assessing sublethal effects, as root and biomass changes, in addition to germination, for a more comprehensive phytotoxicity assessment is demonstrated. Standardized test conditions may overlook species requiring specific germination conditions. Sorption of antibiotics to filter paper affected exposure concentrations, emphasizing the importance of chemical quantification before and after tests. This study highlights the need for adaptive phytotoxicity protocols, careful experimental design to obtain statistically significant results, and inclusion of non-cultivated species as bioindicators to better assess antibiotic risks to terrestrial plants.

22 December 2024 in Ceramics International
Verified
Journal Article
Closed access
DHDiana L. Hernández-Arellano
Diana L. Hernández-Arellano
EMEthel G. Méndez-Vélez
Ethel G. Méndez-Vélez
JDJuan C. Durán-Álvarez
Juan C. Durán-Álvarez
SCSilvana Cortés-Lagunes
Silvana Cortés-Lagunes
Rodolfo ZanellaRodolfo Zanella
Rodolfo Zanella
RLRigoberto López
Rigoberto López

12 January 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
IMI. Martínez-Camacho
I. Martínez-Camacho
LDL.F. Donis-Rabanales
L.F. Donis-Rabanales
SCS. Cortés-Lagunes
S. Cortés-Lagunes
Juan Carlos Durán-ÁlvarezJuan Carlos Durán-Álvarez
Juan Carlos Durán-Álvarez
MCM.S. Córdova-Aguilar
M.S. Córdova-Aguilar
Gabriel AscanioGabriel Ascanio
Gabriel Ascanio
A new device has been developed to examine how pharmaceutical tablets dissolve under conditions very similar to those in the human stomach. For that purpose, Prednisone USP compendial standard tablets were dissolved in two different apparatuses. On one side, a distal gastric simulator, known as the in vitro Distal Gastric Simulator (IV-DGS), was used. This simulator closely replicates the physiological conditions of the human stomach. It can mimic its operating environment, including peristaltic movement at 3 cycles per minute and an average maximum pressure of about 25 mm Hg. The results from the gastric simulator were compared with the dissolution rates measured using the United States Pharmacopeia-approved apparatus 2. The results show that after 12 min, the USP Apparatus 2 achieved 71.5% dissolution, while the IV-DGS reached 24.9%, indicating a slower dissolution rate but a more realistic gastric mixing. The dissolution data from both systems were modeled using a first-order and a Weibull model, with the latter providing a better fit. Although the results are not entirely comparable with USP 2, the gastric simulator offers a much more realistic alternative for in vitro drug dissolution studies.